Dentsply Sirona/$XRAY

13:30
09:10
04:45
00:25
20:00
1D1W1MYTD1Y5YMAX

About Dentsply Sirona

Dentsply Sirona is one of the world's largest manufacturers of dental equipment and supplies. It is a result of a merger of equals in 2016 between Dentsply International (dental consumables and lab products) and Sirona Dental Systems (technologically advanced dental equipment). The firm's wide portfolio consists of dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantation. It distributes two-thirds of its dental consumables, technology, and equipment through third-party distributors. The remaining portfolio is either sold to labs and offices through the firm's salesforce or directly to consumers (such as the Byte clear aligner).

Ticker

$XRAY
Sector
Primary listing

Employees

14,000

Dentsply Sirona Metrics

BasicAdvanced
$2.5B
-
-$4.76
0.97
$0.64
5.11%

What the Analysts think about Dentsply Sirona

Analyst ratings (Buy, Hold, Sell) for Dentsply Sirona stock.

Bulls say / Bears say

Dentsply Sirona issued $550 million of 8.375% junior subordinated notes due 2055 on June 12, 2025, to repay its $435 million bridge loan without prepayment penalties, extending debt maturities and bolstering financial flexibility (Reuters)
Adjusted EBITDA margin expanded to 19.0% in Q1 2025 from 16.8% a year earlier, reflecting effective cost controls and operational efficiencies despite market headwinds (GlobeNewswire)
Management reaffirmed its full‐year 2025 guidance—organic sales down 4.0% to 2.0% and adjusted EPS of $1.80–$2.00—signaling confidence in its transformation initiatives and long-term strategy (GlobeNewswire)
Moody’s revised Dentsply Sirona’s outlook to negative on March 18, 2025, citing continued growth challenges and earnings uncertainty from weak high-dollar equipment sales that could strain its credit metrics (Reuters)
Organic sales fell 4.4% in Q1 2025, including a 17.7% decline in Orthodontic & Implant Solutions, underscoring persistent end-market softness in both consumables and technology segments (GlobeNewswire)
Operating cash flow plunged 72% to $7 million in Q1 2025 from $25 million a year earlier, strained by receivables timing and inventory build, highlighting liquidity and working-capital pressures (GlobeNewswire)
Data summarised monthly by Lightyear AI. Last updated on 6 Oct 2025.

Dentsply Sirona Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Dentsply Sirona Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $XRAY

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

FAQs